COVID-19
Top health officials and medics have welcomed promising developments in the production of Covid-19 vaccines, with several pharma firms reporting advances in their trials and large-scale production. However, despite these positive news, experts warn that it could be autumn next year before widespread vaccination of the population is possible. Health
Vaccines
The US is experiencing a devastating surge in COVID-19 cases, with a record number of infections reported over the weekend. As the country struggles to contain the pandemic, there are also concerns about the efficacy of new treatments and vaccines. Gilead Sciences' COVID-19 treatment, remdesivir, has been approved by
Vaccines
The University of Oxford's COVID-19 experimental vaccine has produced a robust immune response in both young and old adults, raising hopes of a path out of the COVID-19 pandemic. The vaccine, developed by the University of Oxford and manufactured by AstraZeneca Plc, triggers lower adverse responses among the
Vaccines
A new study published in the American Journal of Public Health has found that social media, particularly Pinterest, can significantly influence the way people search for and access information about the human papillomavirus (HPV) vaccine. According to the study, conducted by researchers at VCU Massey Cancer Center, the majority of
Vaccines
The Trump Administration's Operation Warp Speed initiative has taken a significant step forward with the announcement of a pharmacy partnership between the U.S. Department of Health and Human Services (HHS), the Department of Defense (DoD), CVS, and Walgreens. The partnership aims to provide and administer COVID-19 vaccines
Vaccines
Stock futures rose modestly ahead of earnings reports from Bank of America and Wells Fargo, as investors weigh setbacks in coronavirus vaccine development and treatment. Apple launched several new products, including the iPhone 12, which includes a new 5G-capable device. ConocoPhillips is reportedly in talks to acquire rival Concho Resources,
Vaccines
As the confirmation hearings for Supreme Court nominee Amy Coney Barrett continue, the nation remains distracted by various national stories, including the pause of a COVID-19 vaccine trial and Facebook's efforts to curb Holocaust denial posts. In the midst of these developments, the five men accused of plotting
Vaccines
The US Food and Drug Administration has outlined its rigorous requirements for emergency use authorization (EUA) of potential coronavirus vaccines, making it challenging for manufacturers to apply for EUA by Election Day or the end of October. The FDA wants to see at least two months of follow-up safety data
Vaccines
As the world awaits the development of a COVID-19 vaccine, infectious diseases specialists at Greater Boston hospitals emphasize the importance of rigorous safety and efficacy standards before distribution. A single-dose vaccine being developed by Johnson and Johnson has begun a final study to prove its effectiveness in protecting against the
Vaccines
Inovio Pharmaceuticals' development of its COVID-19 vaccine candidate, INO-4800, has hit a roadblock as the U.S. Food and Drug Administration (FDA) has put the Phase II/III trial on partial clinical hold, citing additional questions about the vaccine and its delivery device, the Cellectra 2000. This move comes
Vaccines
INOVIO Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has put its planned Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800 on partial clinical hold, citing additional questions about the company's delivery device, CELLECTRA 2000. Despite this setback, INOVIO is actively
Vaccines
With the US surpassing 200,000 deaths due to COVID-19, a group of pediatric infectious disease specialists is urging the acceleration of vaccine trials for children. The specialists warn that the current pace of vaccine development for adults is not translating to progress in pediatric trials, leaving children "stuck
